source
- European regulators recommend Sanofi's MS drug tolebrutinib for approval after US rejectionEuropean Medicines Agency officials issued a positive recommendation for tolebrutinib, an experimental multiple sclerosis therapy from Sanofi, after the U.S. FDA rejected the drug earlier this year…
- FDA to fast-track review of three psychedelic therapies for depression and PTSDThe FDA announced it will accelerate the review of psychedelic drugs from three companies as part of a broader initiative to increase access to mental-health treatments. Compass Pathways will rece…